Global COVID-19 Saliva Screening Test Market Size, Status and Forecast 2021-2027

Global COVID-19 Saliva Screening Test Market Size, Status and Forecast 2021-2027

  • QYResearch
  • November 2021
  • Healthcare
  • 106 pages

Report Description

Global COVID-19 Saliva Screening Test Scope and Market Size
COVID-19 Saliva Screening Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global COVID-19 Saliva Screening Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Fluorescence-labelled Antigen
RT-PCR
CRISPR-Cas9

Segment by Application
Hospital
Clinic
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Psomagen, Inc
ARUP Labs
Vatic Health
MOgene
Fluidigm Corporation
Phosphorus Diagnostics LLC
Quidel Corporation
Abbot Laboratories
FLuroTech Ltd
LumiraDX
Gravity Diagnostics
Ambry Genetics
DxTerity Diagnostics

Have query on this report?

Make an Enquiry
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Saliva Screening Test Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fluorescence-labelled Antigen
List of Tables
Table 1. Global COVID-19 Saliva Screening Test Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fluorescence-labelled Antigen
Table 3. Key Players of RT-PCR
Table 4. Key Players of CRISPR-Cas9
Table 5. Global COVID-19 Saliva Screening Test Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

Success Stories

Our Clients